1. Home
  2. LNKS vs AFMD Comparison

LNKS vs AFMD Comparison

Compare LNKS & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNKS
  • AFMD
  • Stock Information
  • Founded
  • LNKS 1995
  • AFMD 2000
  • Country
  • LNKS Malaysia
  • AFMD Germany
  • Employees
  • LNKS N/A
  • AFMD N/A
  • Industry
  • LNKS
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • LNKS
  • AFMD Health Care
  • Exchange
  • LNKS NYSE
  • AFMD Nasdaq
  • Market Cap
  • LNKS 9.1M
  • AFMD 10.2M
  • IPO Year
  • LNKS 2024
  • AFMD 2014
  • Fundamental
  • Price
  • LNKS $0.63
  • AFMD $0.89
  • Analyst Decision
  • LNKS
  • AFMD Strong Buy
  • Analyst Count
  • LNKS 0
  • AFMD 5
  • Target Price
  • LNKS N/A
  • AFMD $13.50
  • AVG Volume (30 Days)
  • LNKS 200.5K
  • AFMD 121.8K
  • Earning Date
  • LNKS 05-11-2025
  • AFMD 06-11-2025
  • Dividend Yield
  • LNKS N/A
  • AFMD N/A
  • EPS Growth
  • LNKS N/A
  • AFMD N/A
  • EPS
  • LNKS N/A
  • AFMD N/A
  • Revenue
  • LNKS $5,088,489.00
  • AFMD $6,287,085.00
  • Revenue This Year
  • LNKS N/A
  • AFMD N/A
  • Revenue Next Year
  • LNKS N/A
  • AFMD $225.65
  • P/E Ratio
  • LNKS N/A
  • AFMD N/A
  • Revenue Growth
  • LNKS N/A
  • AFMD N/A
  • 52 Week Low
  • LNKS $0.45
  • AFMD $0.52
  • 52 Week High
  • LNKS $10.27
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • LNKS N/A
  • AFMD 61.98
  • Support Level
  • LNKS N/A
  • AFMD $0.70
  • Resistance Level
  • LNKS N/A
  • AFMD $0.85
  • Average True Range (ATR)
  • LNKS 0.00
  • AFMD 0.08
  • MACD
  • LNKS 0.00
  • AFMD 0.03
  • Stochastic Oscillator
  • LNKS 0.00
  • AFMD 97.37

About LNKS LINKERS INDUSTRIES LIMITED

Linkers Industries Ltd is a company which acts as a manufacturer and a supplier of wire, cable harnesses with their manufacturing operations in Malaysia. Wire/cable harness refers to an assembly of wires/cables bound together with straps, cable ties and electrical tapes to transmit signals or electrical power. Company works closely with customers in each stage of a product's life cycle, including design, prototyping and production. Geographically company provides services in Thailand, Malaysia, Switzerland, United States of America, and many others, maximum revenue gained from Thailand.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: